SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-085437
Filing Date
2024-04-03
Accepted
2024-04-03 07:31:06
Documents
52
Period of Report
2024-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d794675d8k.htm   iXBRL 8-K 70646
2 EX-2.1 d794675dex21.htm EX-2.1 596983
3 EX-3.1 d794675dex31.htm EX-3.1 69110
4 EX-10.1 d794675dex101.htm EX-10.1 48184
5 EX-10.2 d794675dex102.htm EX-10.2 112958
6 EX-10.3 d794675dex103.htm EX-10.3 44793
7 EX-10.4 d794675dex104.htm EX-10.4 27979
8 EX-99.1 d794675dex991.htm EX-99.1 30058
9 EX-99.2 d794675dex992.htm EX-99.2 38033
10 EX-99.3 d794675dex993.htm EX-99.3 18737
14 GRAPHIC g794675ex99_2s10g1.jpg GRAPHIC 83945
15 GRAPHIC g794675ex99_2s11g1.jpg GRAPHIC 80691
16 GRAPHIC g794675ex99_2s12g1.jpg GRAPHIC 79596
17 GRAPHIC g794675ex99_2s13g1.jpg GRAPHIC 88064
18 GRAPHIC g794675ex99_2s14g1.jpg GRAPHIC 84473
19 GRAPHIC g794675ex99_2s15g1.jpg GRAPHIC 96362
20 GRAPHIC g794675ex99_2s16g1.jpg GRAPHIC 81942
21 GRAPHIC g794675ex99_2s17g1.jpg GRAPHIC 102900
22 GRAPHIC g794675ex99_2s18g1.jpg GRAPHIC 99770
23 GRAPHIC g794675ex99_2s19g1.jpg GRAPHIC 58877
24 GRAPHIC g794675ex99_2s1g1.jpg GRAPHIC 81813
25 GRAPHIC g794675ex99_2s20g1.jpg GRAPHIC 95937
26 GRAPHIC g794675ex99_2s21g1.jpg GRAPHIC 68646
27 GRAPHIC g794675ex99_2s22g1.jpg GRAPHIC 105068
28 GRAPHIC g794675ex99_2s23g1.jpg GRAPHIC 87166
29 GRAPHIC g794675ex99_2s24g1.jpg GRAPHIC 72689
30 GRAPHIC g794675ex99_2s25g1.jpg GRAPHIC 85802
31 GRAPHIC g794675ex99_2s26g1.jpg GRAPHIC 85731
32 GRAPHIC g794675ex99_2s27g1.jpg GRAPHIC 62339
33 GRAPHIC g794675ex99_2s28g1.jpg GRAPHIC 67842
34 GRAPHIC g794675ex99_2s29g1.jpg GRAPHIC 96201
35 GRAPHIC g794675ex99_2s2g1.jpg GRAPHIC 213890
36 GRAPHIC g794675ex99_2s30g1.jpg GRAPHIC 164150
37 GRAPHIC g794675ex99_2s3g1.jpg GRAPHIC 193171
38 GRAPHIC g794675ex99_2s4g1.jpg GRAPHIC 100271
39 GRAPHIC g794675ex99_2s5g1.jpg GRAPHIC 91643
40 GRAPHIC g794675ex99_2s6g1.jpg GRAPHIC 68673
41 GRAPHIC g794675ex99_2s7g1.jpg GRAPHIC 68835
42 GRAPHIC g794675ex99_2s8g1.jpg GRAPHIC 67157
43 GRAPHIC g794675ex99_2s9g1.jpg GRAPHIC 80775
  Complete submission text file 0001193125-24-085437.txt   5337327

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA abio-20240403.xsd EX-101.SCH 2868
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20240403_lab.xml EX-101.LAB 17994
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20240403_pre.xml EX-101.PRE 11273
55 EXTRACTED XBRL INSTANCE DOCUMENT d794675d8k_htm.xml XML 3631
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 24816849
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)